0.15 CNY
37.62 M CNY
488.48 M CNY
About PHARMARESOURCES (S
Sector
CEO
Ping Chen
Website
Headquarters
Shanghai
Founded
2007
ISIN
CNE1000065Q9
FIGI
BBG00ZKZ9XH2
PharmaResources (Shanghai) Co., Ltd. engages in the biotechnology business. It provides drug discovery, research, development of pharmaceutical processes, and commercial production of API intermediates. The company was founded on December 14, 2007 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 301230 is 25.35 CNY — it has decreased by −0.31% in the past 24 hours. Watch PHARMARESOURCES (S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange PHARMARESOURCES (S stocks are traded under the ticker 301230.
301230 stock has risen by 2.14% compared to the previous week, the month change is a −5.20% fall, over the last year PHARMARESOURCES (S has showed a −17.41% decrease.
301230 reached its all-time high on Jul 14, 2023 with the price of 44.23 CNY, and its all-time low was 16.28 CNY and was reached on Feb 6, 2024. View more price dynamics on 301230 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
301230 stock is 3.87% volatile and has beta coefficient of 1.83. Track PHARMARESOURCES (S stock price on the chart and check out the list of the most volatile stocks — is PHARMARESOURCES (S there?
Today PHARMARESOURCES (S has the market capitalization of 3.52 B, it has decreased by −6.93% over the last week.
Yes, you can track PHARMARESOURCES (S financials in yearly and quarterly reports right on TradingView.
301230 net income for the last quarter is 12.31 M CNY, while the quarter before that showed 3.67 M CNY of net income which accounts for 235.60% change. Track more PHARMARESOURCES (S financial stats to get the full picture.
PHARMARESOURCES (S dividend yield was 0.71% in 2023, and payout ratio reached 72.62%. The year before the numbers were 0.94% and 57.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 1.05 K employees. See our rating of the largest employees — is PHARMARESOURCES (S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMARESOURCES (S EBITDA is 57.53 M CNY, and current EBITDA margin is 15.69%. See more stats in PHARMARESOURCES (S financial statements.
Like other stocks, 301230 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARESOURCES (S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARESOURCES (S technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARESOURCES (S stock shows the neutral signal. See more of PHARMARESOURCES (S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.